Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 113, Issue 13, 3027-3030, March 26, 2009
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

FAS-L, IL-10, and double-negative CD4CD8 TCR {alpha}+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function
Blood Magerus-Chatinet et al. 113: 3027

Supplemental materials for: Magerus-Chatinet et al

Files in this Data Supplement:

  • Figure S1. FAS-mediated apoptosis in ALPS patients (JPG, 42.3 KB) -
    (A) Results for FAS-induced apoptosis in vitro on activated T cells from ALPS patients with FAS mutations, healthy age-matched controls (HCs) and relatives carrying (MPRs) or not (HR) a FAS mutation. (B) Comparison of the FAS-induced apoptosis obtained in parallel for the patients and their relatives carrying the same FAS mutation. Values are expressed as the percentages of PHA-activated T-cell blasts that underwent apoptosis in vitro. The wide horizontal bars denote the mean values for each group. P values for inter-group differences in the Mann-Whitney test are shown above the data.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020